Sun Fan, Zhang Li, Tong Zhongsheng
National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Front Artif Intell. 2025 Jan 7;7:1487207. doi: 10.3389/frai.2024.1487207. eCollection 2024.
The rapid advancement of artificial intelligence (AI) has introduced transformative opportunities in oncology, enhancing the precision and efficiency of tumor diagnosis and treatment. This review examines recent advancements in AI applications across tumor imaging diagnostics, pathological analysis, and treatment optimization, with a particular focus on breast cancer, lung cancer, and liver cancer. By synthesizing findings from peer-reviewed studies published over the past decade, this paper analyzes the role of AI in enhancing diagnostic accuracy, streamlining therapeutic decision-making, and personalizing treatment strategies. Additionally, this paper addresses challenges related to AI integration into clinical workflows and regulatory compliance. As AI continues to evolve, its applications in oncology promise further improvements in patient outcomes, though additional research is needed to address its limitations and ensure ethical and effective deployment.
人工智能(AI)的快速发展为肿瘤学带来了变革性机遇,提高了肿瘤诊断和治疗的精准度与效率。本综述探讨了AI在肿瘤成像诊断、病理分析和治疗优化等方面的最新进展,特别关注乳腺癌、肺癌和肝癌。通过综合过去十年发表的同行评议研究结果,本文分析了AI在提高诊断准确性、简化治疗决策和个性化治疗策略方面的作用。此外,本文还讨论了将AI整合到临床工作流程和监管合规方面的挑战。随着AI不断发展,其在肿瘤学中的应用有望进一步改善患者预后,不过仍需更多研究来解决其局限性,并确保其符合伦理且有效应用。